Genomics England
Oxford Nanopore, UK Government Partner on Biosurveillance, Genomic Healthcare
Oxford Nanopore will work with Genomics England, UK Biobank, and NHS England on a series of initiatives to boost genomics applications in the country.
In a Nature Medicine paper, WGS yielded a clinical benefit for 24 percent of pediatric cancer patients, and directly changed clinical management for 7 percent.
The research study, run by Genomics England in collaboration with the UK's National Health Service, plans to sequence the genomes of 100,000 newborns.
UK Study Supports Use of Whole-Genome Sequencing in Standard Cancer Care
The researchers found that whole-genome sequencing yielded more comprehensive information than relying on cancer panels.
Genomics England, Oxford Nanopore Partner for Project to Diagnose Unsolved Rare Disease Cases
As part of the project, Eurofins Genomics is contracted to perform whole-genome nanopore sequencing on 7,500 samples from the 100,000 Genomes Project.
Aug 7, 2023
Dec 13, 2022
Oct 10, 2022
Jul 22, 2022
May 10, 2022